Market overview
The global aquaculture fungal infection treatment market is worth USD 90 mn in 2026 and is forecast to reach USD 161 mn by 2036, growing at a 6.0% CAGR. China is the largest country market and Formalin-based is the largest by treatment segment.
| Scope | Treatments for fungal and water-mould infections in farmed fish and shrimp, such as saprolegnia: formalin, hydrogen peroxide, peracetic acid, bronopol and other approved antifungal products for hatcheries and grow-out farms. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 85 mn |
| Value 2026 | USD 90 mn |
| Value 2036 | USD 161 mn |
| CAGR 2026-2036 | 6.0% |
| Volume 2026 | 41,980 tonnes |
| Volume 2036 | 68,060 tonnes |
| Average price 2026 | USD 2,146 per tonne |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Aquaculture Fungal Infection Treatment market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 90 mn |
| 2027 | USD 96 mn |
| 2028 | USD 101 mn |
| 2029 | USD 107 mn |
| 2030 | USD 114 mn |
| 2031 | USD 121 mn |
| 2032 | USD 128 mn |
| 2033 | USD 135 mn |
| 2034 | USD 144 mn |
| 2035 | USD 152 mn |
| 2036 | USD 161 mn |
Aquaculture Fungal Infection Treatment market segmentation
By treatment
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Formalin-based | 38.0% | 30.6% | USD 34 mn | 3.7% |
| Hydrogen peroxide and peracetic acid | 27.0% | 30.4% | USD 24 mn | 7.3% |
| Bronopol and other approved antifungals | 20.0% | 23.6% | USD 18 mn | 7.8% |
| Salt, copper and botanical treatments | 15.0% | 15.4% | USD 14 mn | 6.3% |
By species
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Freshwater fish (tilapia, carp, catfish) | 38.0% | 35.9% | USD 34 mn | 5.4% |
| Salmonids | 34.0% | 33.7% | USD 31 mn | 5.9% |
| Shrimp | 18.0% | 20.5% | USD 16 mn | 7.4% |
| Other species | 10.0% | 9.9% | USD 9.0 mn | 5.9% |
By administration
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| In-feed medication | 46.0% | 44.0% | USD 41 mn | 5.5% |
| Immersion bath | 22.0% | 21.0% | USD 20 mn | 5.5% |
| Injection | 12.0% | 12.0% | USD 11 mn | 6.0% |
| Water treatment dosing | 20.0% | 23.0% | USD 18 mn | 7.5% |
By life stage
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hatchery and larvae | 20.0% | 19.0% | USD 18 mn | 5.5% |
| Nursery and fry | 24.0% | 23.0% | USD 22 mn | 5.5% |
| Grow-out | 46.0% | 47.0% | USD 41 mn | 6.2% |
| Broodstock | 10.0% | 11.0% | USD 9.0 mn | 7.0% |
By sales channel
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Direct farm sales | 36.0% | 33.0% | USD 32 mn | 5.1% |
| Distributors | 30.0% | 30.0% | USD 27 mn | 6.0% |
| Feed integrators | 22.0% | 25.0% | USD 20 mn | 7.4% |
| Veterinary clinics | 12.0% | 12.0% | USD 11 mn | 6.0% |
Top 25 countries for aquaculture fungal infection treatment by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 75.0% of 2026 revenue and the 25 countries below together hold 94.8%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | China | USD 25 mn | 28.0% | USD 49 mn | 6.8% |
| 2 | Norway | USD 8.1 mn | 9.0% | USD 12 mn | 4.4% |
| 3 | Chile | USD 7.2 mn | 8.0% | USD 12 mn | 5.3% |
| 4 | India | USD 6.3 mn | 7.0% | USD 13 mn | 7.8% |
| 5 | Indonesia | USD 5.4 mn | 6.0% | USD 10 mn | 6.8% |
| 6 | Vietnam | USD 4.5 mn | 5.0% | USD 8.7 mn | 6.8% |
| 7 | United States | USD 3.6 mn | 4.0% | USD 5.8 mn | 4.9% |
| 8 | Egypt | USD 2.7 mn | 3.0% | USD 5.0 mn | 6.3% |
| 9 | Canada | USD 2.2 mn | 2.5% | USD 3.4 mn | 4.2% |
| 10 | Bangladesh | USD 2.2 mn | 2.5% | USD 4.5 mn | 7.2% |
| 11 | Ecuador | USD 2.2 mn | 2.4% | USD 3.6 mn | 5.2% |
| 12 | Thailand | USD 2.2 mn | 2.4% | USD 3.6 mn | 5.2% |
| 13 | Japan | USD 2.0 mn | 2.2% | USD 3.0 mn | 4.0% |
| 14 | Philippines | USD 1.8 mn | 2.0% | USD 3.0 mn | 5.2% |
| 15 | Brazil | USD 1.6 mn | 1.8% | USD 2.7 mn | 5.2% |
| 16 | Malaysia | USD 1.4 mn | 1.6% | USD 2.4 mn | 5.2% |
| 17 | Taiwan | USD 1.1 mn | 1.2% | USD 1.8 mn | 5.2% |
| 18 | South Korea | USD 1.1 mn | 1.2% | USD 1.7 mn | 5.2% |
| 19 | Mexico | USD 0.86 mn | 1.0% | USD 1.4 mn | 5.2% |
| 20 | Peru | USD 0.83 mn | 0.9% | USD 1.4 mn | 5.3% |
| 21 | Turkey | USD 0.68 mn | 0.8% | USD 1.1 mn | 5.1% |
| 22 | Iran | USD 0.56 mn | 0.6% | USD 0.92 mn | 5.1% |
| 23 | United Kingdom | USD 0.52 mn | 0.6% | USD 0.77 mn | 4.0% |
| 24 | Denmark | USD 0.50 mn | 0.6% | USD 0.74 mn | 4.1% |
| 25 | Myanmar | USD 0.50 mn | 0.6% | USD 0.82 mn | 5.2% |
| Rest of world | USD 4.7 mn | 5.2% | USD 7.6 mn | 4.9% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Zoetis
- Elanco
- Merck Animal Health
- Pharmaq
- Evonik
- Solvay
Group 2: Regional and specialist players
- Veterquimica
- Western Chemical
- Argent Chemical Laboratories
- Benchmark Holdings
Group 3: Emerging and niche players
- Syndel
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the aquaculture fungal infection treatment market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 6.0% is calculated from the resulting values.
The market is divided by treatment, by species, by administration, by life stage, by sales channel. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the aquaculture fungal infection treatment market?
The global aquaculture fungal infection treatment market is estimated at USD 85 mn in 2025 and USD 90 mn in 2026.
How fast will the aquaculture fungal infection treatment market grow?
It is forecast to reach USD 161 mn by 2036, a compound annual growth rate of 6.0% from 2026, an increase of USD 71 mn.
Which country is the largest market for aquaculture fungal infection treatment?
China is the largest market by revenue at USD 25 mn in 2026, 28.0% of the global total. The three largest countries together hold 45.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 7.8% a year from 2026 to 2036.
Which aquaculture fungal infection treatment segment is largest?
In the by treatment split, Formalin-based is the largest segment with 38.0% of 2026 revenue.
Who are the leading aquaculture fungal infection treatment companies?
Global leaders include Zoetis, Elanco, Merck Animal Health, Pharmaq.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Bioabsorbable StentsUSD 92 mn · 7.0% CAGR
- Lacrimal DevicesUSD 87 mn · 5.0% CAGR
- Ostomy Irrigation ProductsUSD 94 mn · 4.3% CAGR
- Brachytherapy Treatment Planning SystemsUSD 95 mn · 5.8% CAGR
- Vaccine CryoprotectantsUSD 81 mn · 8.0% CAGR
- Breast Cancer Grading ToolsUSD 102 mn · 17.0% CAGR
- Federated Learning Drug DiscoveryUSD 104 mn · 20.0% CAGR
- Federated Learning HealthcareUSD 78 mn · 22.0% CAGR